Ken Griffin Curis Inc Put Options Transaction History

Citadel Advisors LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	SELL	$0.57 - $0.99 $113 - $198	-200 Reduced 40.0%	300 $0
Q1 2023 May 15, 2023	SELL	$0.51 - $0.78 $5,304 - $8,112	-10,400 Reduced 95.41%	500 $0
Q4 2022 Feb 14, 2023	SELL	$0.47 - $17.22 $282 - $10,332	-600 Reduced 5.22%	10,900 $5,000
Q3 2022 Nov 14, 2022	SELL	$0.74 - $15.01 $1,036 - $21,014	-1,400 Reduced 10.85%	11,500 $8,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $297M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.